ALLIANCEBERNSTEIN L.P. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$68,704
-35.2%
30,4000.0%0.00%
Q4 2022$106,096
-84.0%
30,400
+69.8%
0.00%
Q3 2022$663,000
-54.7%
17,900
-76.8%
0.00%
-100.0%
Q2 2022$1,463,000
+202.9%
77,032
+330.3%
0.00%
Q1 2022$483,000
+19.9%
17,9000.0%0.00%
Q4 2021$403,000
-14.1%
17,9000.0%0.00%
Q3 2021$469,000
-18.2%
17,9000.0%0.00%
Q2 2021$573,000
+3.6%
17,900
+14.0%
0.00%
Q1 2021$553,000
+9.9%
15,7000.0%0.00%
Q4 2020$503,000
-23.2%
15,700
-9.8%
0.00%
Q3 2020$655,000
-18.7%
17,400
-3.3%
0.00%
Q2 2020$806,00018,0000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders